Treatment evaluation for a data-driven subgroup in adaptive enrichment designs of clinical trials
- PMID: 28948633
- DOI: 10.1002/sim.7497
Treatment evaluation for a data-driven subgroup in adaptive enrichment designs of clinical trials
Abstract
Adaptive enrichment designs (AEDs) of clinical trials allow investigators to restrict enrollment to a promising subgroup based on an interim analysis. Most of the existing AEDs deal with a small number of predefined subgroups, which are often unknown at the design stage. The newly developed Simon design offers a great deal of flexibility in subgroup selection (without requiring pre-defined subgroups) but does not provide a procedure for estimating and testing treatment efficacy for the selected subgroup. This article proposes a 2-stage AED which does not require predefined subgroups but requires a prespecified algorithm for choosing a subgroup on the basis of baseline covariate information. Having a prespecified algorithm for subgroup selection makes it possible to use cross-validation and bootstrap methods to correct for the resubstitution bias in estimating treatment efficacy for the selected subgroup. The methods are evaluated and compared in a simulation study mimicking actual clinical trials of human immunodeficiency virus infection.
Keywords: bootstrap; cross-validation; precision medicine; predictive biomarker; subgroup analysis; treatment effect heterogeneity.
Copyright © 2017 John Wiley & Sons, Ltd.
Similar articles
-
Interim treatment selection with a flexible selection margin in clinical trials.Stat Med. 2013 Jul 10;32(15):2529-43. doi: 10.1002/sim.5693. Epub 2012 Dec 5. Stat Med. 2013. PMID: 23212767
-
Point estimation in adaptive enrichment designs.Stat Med. 2017 Nov 10;36(25):3935-3947. doi: 10.1002/sim.7412. Epub 2017 Aug 7. Stat Med. 2017. PMID: 28783881
-
Biomarker driven population enrichment for adaptive oncology trials with time to event endpoints.Stat Med. 2014 Nov 20;33(26):4515-31. doi: 10.1002/sim.6272. Epub 2014 Jul 30. Stat Med. 2014. PMID: 25130879
-
Response-adaptive designs for continuous treatment responses in phase III clinical trials: A review.Stat Methods Med Res. 2016 Feb;25(1):81-100. doi: 10.1177/0962280212441424. Epub 2012 Mar 16. Stat Methods Med Res. 2016. PMID: 22425657 Review.
-
Adaptive designs for confirmatory clinical trials with subgroup selection.J Biopharm Stat. 2014;24(1):168-87. doi: 10.1080/10543406.2013.857238. J Biopharm Stat. 2014. PMID: 24392984 Review.
Cited by
-
Bayesian Approaches to Subgroup Analysis and Related Adaptive Clinical Trial Designs.JCO Precis Oncol. 2019 Oct 24;3:PO.19.00003. doi: 10.1200/PO.19.00003. eCollection 2019. JCO Precis Oncol. 2019. PMID: 32923858 Free PMC article. Review.
-
A two-stage adaptive clinical trial design with data-driven subgroup identification at interim analysis.Pharm Stat. 2022 Sep;21(5):1090-1108. doi: 10.1002/pst.2208. Epub 2022 Mar 24. Pharm Stat. 2022. PMID: 35322520 Free PMC article.
-
IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapy.BMC Med Res Methodol. 2023 Mar 20;23(1):66. doi: 10.1186/s12874-023-01877-w. BMC Med Res Methodol. 2023. PMID: 36941537 Free PMC article.
-
Multi-stage adaptive enrichment trial design with subgroup estimation.J Biopharm Stat. 2020 Nov 1;30(6):1038-1049. doi: 10.1080/10543406.2020.1832109. Epub 2020 Oct 18. J Biopharm Stat. 2020. PMID: 33073685 Free PMC article.
-
Toward Precision in Critical Care Research: Methods for Observational and Interventional Studies.Crit Care Med. 2024 Sep 1;52(9):1439-1450. doi: 10.1097/CCM.0000000000006371. Epub 2024 Aug 15. Crit Care Med. 2024. PMID: 39145702 Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical